We adjusted for factors including patient sex, social vulnerability, BMI classification, race, ethnicity, and age
Do GLP-1 medicines increase cancer risk in general
Traditional management strategies such as lifestyle modification and behavioral therapy often lead to modest weight loss, but maintaining these results long-term remains a significant challenge due to physiological adaptations that favor weight regain [2]
As a class of drugs, GLP-1s have been shown to result in weight loss.[2] Common side effects of GLP-1s include nausea, vomiting, diarrhea, constipation, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, and gastroenteritis.[1-4] All GLP-1s carry a boxed warning for the risk of thyroid c-cell tumors and a contraindication for a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2